The article is associated with the American College of Prosthodontists' journal-based continuing education program. It is accompanied by an online continuing education activity worth 1 credit. Please visit www.wileyhealthlearning.com/jopr to complete the activity and earn credit. 
Surgical midfacial reconstruction following tumor ablation is challenging, as it attempts to achieve many objectives. These include: supporting the orbital contents; cosmetic improvement of the exenterated orbit; maintenance of a patent nasal airway with oronasal separation; provision of a stable oral platform for mastication and speech; and recreation of symmetrical contours of the reconstructed site with that of the contralateral face. 1 While advancements in head and neck surgery, via the use of microvascular techniques and free tissue transfers, have enabled surgeons to reconstruct missing structures and achieve many of these goals, this is not always possible in the midfacial region. 2 Currently, no single reconstructive technique is able to achieve all these goals. Thus, a multidisciplinary approach is advocated. 3 The incorporation of prosthetic appliances in these reconstructions has been shown to provide excellent results. 3 The fabricated facial prostheses can replace large sections of hard and soft tissues, and can be sculpted to mimic anatomical contours and details while simultaneously avoiding the tissue distortion often associated with surgical reconstruction. Being removable, they also allow for cleaning and regular surveillance of the tumor resection site. 4, 5 Extraoral implants have been used successfully for many years for prosthesis fixation in the auricular, orbital, and nasal regions. 4 In patients with extensive midfacial defects, combining craniofacial prostheses with intraoral dentures allows for near complete restoration of both cosmetic and functional requirements. This is also less invasive, as it eliminates the need for further surgical reconstruction. 6 Zygomatic implants were originally developed for restoring extensively resorbed posterior maxillae without the need for further bone augmentation. 7 In severe defects, resulting from partial or complete maxillectomies, it has been found that these implants can also provide adequate retention for craniofacial prostheses. 8 They allow fullarch reconstructions in severe defects, and can also be used to support extraoral nasal prostheses in cases with oronasal communication. 6 Using prosthetic devices to reconstruct maxillary defects following tumor resection allows for visual examination of the resected site for signs of possible superficial recurrence. Though imaging modalities have improved significantly for monitoring such recurrence, early visual detection could possibly prevent further aggressive surgery. This can only be achieved prosthetically, therefore, the current literature still supports the need for extraoral prosthetic devices to rehabilitate large midfacial defects. 6, [8] [9] [10] [11] [12] [13] This paper discusses four patients who were all left with extensive maxillary defects following tumor resection. All four had zygomatic implants immediately placed at the time of tumor resection surgery. These implants aided in the immediate provisionalization of these patients, as they retained and supported craniofacial prostheses and obturators/intraoral dentures.
Clinical reports
Four patients, all requiring orofacial rehabilitation following extensive midfacial tumor resective surgery involving most of their maxillae (subtotal maxillectomy), are discussed. The resulting defects all needed some form of facial and oro-dental prostheses for rehabilitation. The aggressive nature of these tumors also necessitated some patients to undergo postoperative radiation or chemotherapy.
Zygomatic implant positioning was discussed during the presurgical planning phase for each patient, and marked on the 3D stereolithographic model obtained for each patient. This gave the surgeons an approximate indication of implant angulation during insertion and the depth of placement. The implants were placed at the time of tumor resection in all patients, and these patients were immediately provisionalized with interim dentures and facial prostheses where necessary. Regular recall appointments were scheduled for all patients to monitor their progress, and adjustments were made to their devices in accordance with the tissue changes encountered during healing. Definitive prostheses were manufactured after adequate recovery had taken place (within the following 3 to 6 months).
Patient 1
A 77-year-old male patient presented with a swelling in his right paranasal sinus region. Medical history revealed that he had undergone tumor resection for a basal cell carcinoma of this area 10 years previously. Recurrences had since occurred on two separate occasions. In both instances, the tumors had been removed, and the defective site surgically reconstructed with local flaps followed by a course of radiotherapy.
At the time of presentation, his third tumor recurrence, radiological and histological findings revealed that it had spread widely, resulting in destructive infiltration of the palate, upper lip, and nasal cavity. Clinically, the patient's anterior maxillary teeth were mobile, and he had a bloody discharge from his nose, and reported to be experiencing blockage of both nasal passages.
Computed tomography (CT) scans were taken to assess tumor extension. DICOM (digital communication in medicine) files from these scans were transferred into a computer software program (Mimics; Materialise NV, Leuven, Belgium) for 3D data processing. Once processed, this data was converted into standard tessellation/triangulation language (.stl) file format, which is the standard used for rapid prototyping (RP) and 3D model printing. A 3D model of the patient's maxilla and associated structures was then manufactured, and used for presurgical planning. Together with the surgical team, this model was used to plan the extent of the resective surgery and the positioning of zygomatic implants. Once consensus was reached on this, the model was trimmed accordingly (model surgery), and a duplicate plaster cast was manufactured. This cast was then used to fabricate a partial denture, which would be fitted at the time of resective surgery.
The patient's skin tone was acquired with a spectrophotometer (Quickweigh; Spectromatch Ltd., Bath, UK), and a 3D facial scan was taken of the patient's face preoperatively, using a laser scanner (Vivid 910; Konica Minolta Inc., Morrisville, NC). The proposed defect was sculpted on specialized software (Freeform Modelling v12, Geomagic; 3D Systems Corp., Rock Hill, SC) (Fig 1) , after which another 3D model was manufactured. From this model, a wax replica of the nose was made, and an interim nasal prosthesis was manufactured from silicone (Fig 2) .
Surgery involved resection of the entire maxilla anterior to the maxillary second molars en bloc, including the nose, nasal cavity, and parts of the cheek. Once completed, two zygomatic implants were immediately placed into the zygomatic buttress on either side, as these are areas of good bone density. Titanium cylinders were then attached to these implants, and the dental prosthesis was altered and luted to these cylinders with a selfcuring, soft denture relining material (Ufi Gel SC; Voco GmbH, Cuxhaven, Germany) (Fig 3) . Titanium screws were then used to retain the dental prosthesis (obturator), and the interim facial prosthesis was fitted and retained by a central magnet attached to the dental prosthesis (Fig 4) .
The patient underwent an uneventful recovery, and was followed-up monthly for 3 months. Definitive dental and facial prostheses will be manufactured and fitted after 6 months.
Patient 2
A 66-year-old male patient presented with a large maxillary lesion that had been present for more than 3 years. CT scans revealed an extensive radiolucent mass that had obliterated the entire right maxillary antrum, with erosion crossing the midline and extending into the nasal cavity. Incisional biopsy and histological examination of the lesion diagnosed this as an ameloblastoma.
The scans revealed that the tumor extended from the right maxillary third molar to the left maxillary bicuspid. Presurgical planning was done on a 3D printed model of the patient's maxilla, which was obtained in a similar manner to that described for patient 1 above. Following model surgery, and duplicate cast manufacture, an interim clear acrylic obturator was then manufactured prior to surgery. Complete surgical excision of the tumor was obtained through bilateral subtotal maxillectomies, a process whereby the orbital floors are left intact.
14 Three oncology implants were then inserted, two in the right zygoma and one horizontally in the left maxilla (Fig 5) . Zygomatic oncology implants are slightly modified zygomatic implants with a smooth, nonthreaded machined surface along the coronal aspect of their bodies. This produces a maintainable surface that allows for soft tissue integration and prosthesis retention. Titanium cylinders were attached to the implants using titanium screws, and perforations were made in the obturator in the areas where it was to fit over the cylinders once in position. The obturator was luted to these cylinders intraoperatively by means of a fast setting acrylic resin material (Protemp; 3M ESPE, St. Paul, MN). Once the material had set, the titanium cylinders were loosened from the implants, and the obturator was trimmed and polished. The defect was then packed with sterile bismuth iodine paraffin paste (BIPP) impregnated gauze, and the obturator was fixed into position onto the implants using titanium screws (Fig 6) . BIPP-impregnated gauze is commonly used following maxillectomies, as it seals defects and has excellent astringent and antiseptic properties, which aid postoperative healing. 15 Following 3 months of uneventful healing, an implant-supported titanium milled bar with Locator attachments was manufactured and fitted to support and retain an overdenture/obturator prosthesis (Figs 7 and 8 ).
Patient 3
A 44-year-old male patient consulted a dentist for pain in his maxillary right lateral incisor. The tooth was treated endodontically, as the pain was thought to have been of endodontic origin, but the pain never subsided. Upon clinical reexamination, an abnormal mass was noted on the buccal mucosa in this region. The patient was then referred to a maxillofacial and oral surgeon, who performed an incisional biopsy of the mass, which was then diagnosed as a chondroblastic osteosarcoma upon histological examination. CT scans showed extensive tumor infiltration into the right maxillary antrum. Chemotherapy was initiated to reduce the size of the mass, so that complete tumor excision could be accomplished with surgery. Once chemotherapy was complete, new CT scans were taken and 3D models were manufactured for presurgical planning. A dental prosthesis and obturator were then constructed prior to tumor excision.
Tumor removal involved a subtotal maxillectomy of the right maxilla, followed by the placement of two zygomatic implants into the right zygoma. The right orbital floor was reconstructed with a prefabricated titanium meshwork scaffold, and an immediate obturator and dental prosthesis was inserted (Fig 9) . Histological examination of the resected maxilla revealed the presence of residual tumor at the posterior margin, for which the patient had to undergo surgical removal of the pterygoid plates and additional chemotherapy. Subsequent healing and recovery were uneventful, and a definitive overdenture/obturator on an implant-retained titanium bar were fabricated to restore the patient to full speech and masticatory function, 3 months after tumor ablative surgery (Fig 10) .
Patient 4
A 73-year-old female patient presented with a diagnosed squamous cell carcinoma involving the right maxilla, alveolus, palate, and buccal mucosa. CT and magnetic resonance imaging (MRI) scans revealed extensive tumor infiltration into the right maxillary sinus and the nasal septum. As before, these scans were used to produce 3D models of the patient's maxilla and mandible, to assist in preoperative surgical planning, and dental prosthesis/obturator fabrication. Surgical removal involved a right subtotal maxillectomy, during which time two zygomatic implants were placed into the right zygoma. These implants retained the immediate obturator and dental prosthesis (Figs 11 and 12 ) securely via titanium screws. The patient then underwent a course of postoperative radiotherapy. Recovery was uneventful, and a definitive prosthesis was manufactured and inserted 6 months later.
Discussion
Surgical resection of oral and midfacial tumors often leads to considerable facial disfigurement and oral dysfunction, with potentially major psychosocial implications. 9 Advances in technology along with increased interdisciplinary collaboration have made it possible to restore function and esthetics to these patients immediately, or very soon after devastating surgery. This greatly improves their postoperative recovery time and quality of life.
It has been advised that when using zygomatic implants to support prostheses in large maxillary defects, these should be allowed a 4-to 6-month period for osseintegration prior to loading. 6 Studies have shown, however, that even with this delay, there is a 25% implant failure rate. 10 Interestingly, all these failures occurred before loading, suggesting that other factors could be implicated in their failure. The main nonmechanical contributor to this failure was radiation therapy in these patients. 10 Studies have also shown that placement of implants, before radiotherapy, at the time of the tumor ablative surgery, greatly improves their chance of survival. 11, 12 Benefits of this are that osseointegration can take place prior to the harmful effects of radiotherapy, and to avoid further surgery at a later stage to aid the orofacial rehabilitation. 11 Based on these results, our multidisciplinary team has decided to immediately place zygomatic implants at the time of resective surgeries, and prior to radiotherapy commencement. These implants can achieve primary bicortical stability even when large parts of the maxilla have been resected, and may be the only option for stabilizing an obturator prosthesis. 16 Their immediate placement combined with immediate provisionalization with obturators, dental, and facial prostheses has been shown to be advantageous in improving postoperative functional and psychological well-being and recovery in these patients. These patients are no longer burdened by the additional difficulties of eating, communicating, and socializing, while at the same time trying to come to terms with their devastating and life-changing surgery. Though several studies have reported on the success of these implants in restoring maxillectomy defects, [17] [18] [19] very few 9 have reported on their immediate placement at the time of resection with immediate obturation. To the best of the authors' knowledge, there are no reports in the current literature regarding immediate provisionalization in patients with mid-facial defects following maxillary tumor ablative surgery.
Although this treatment modality promises to be a viable and valuable option in selected patients, it is reliant on close cooperation of all members of the multi-disciplinary team, along with careful and meticulous surgical and prosthodontic planning. For most cases involving maxillary tumor resection, the authors suggest the following treatment protocol:
r Preoperative CT scans of the head and neck region (incorporating tumor sites and surrounding tissues), as well as facial scans, if possible r 3D model production (via RP/3D printing) r Multi-disciplinary presurgical planning and model surgery to establish extent of resections and positioning of zygomatic implants r Duplication of resected models into plaster casts r Fabrication of dental/obturator and facial prostheses on duplicate casts r Intraoperative tumor resection, with immediate zygomatic implant placement r Intraoperative modification of dental/obturator prostheses, so that these are retained and supported by the zygomatic implants (prostheses are connected to the implants by titanium cylinders, screws, and self-curing relining materials)
r Sealing residual defects with BIPP gauze Patients should be monitored on a regular basis (monthly), and definitive prostheses should be fabricated within 3 to 6 months following surgery. The use of zygomatic implants allows for constant surveillance of the resected site, and facial prostheses will usually require replacement every 1.5 to 2 years. 13 
Conclusion
The placement of zygomatic implants at the time of tumor ablative surgery to aid in the retention of oral and facial prostheses has been found to be a viable treatment option. Loading the implants and immediately placing an interim prosthesis at the time of tumor resection greatly improves postoperative patient recovery and comfort, as it improves patients' ability to cope with often devastating facial and functional defects. Due to the aggressive nature of orofacial tumors, most patients require postoperative radiotherapy. This is known to be associated with harmful effects on hard and soft tissues, and these effects can affect healing and osseointegration. The added advantage of placing implants at the time of tumor resection is that osseintegration can occur before radiotherapy is initiated.
